|
1.
|
Rosen CB, Nagorney DM, Wiesner RH, Coffey
RJ Jr and LaRusso NF: Cholangiocarcinoma complicating primary
sclerosing cholangitis. Ann Surg. 213:21–25. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Bergquist A, Ekbom A, Olsson R, et al:
Hepatic and extrahepatic malignancies in primary sclerosing
cholangitis. J Hepatol. 36:321–327. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Burak K, Angulo P, Pasha TM, Egan K, Petz
J and Lindor KD: Incidence and risk factors for cholangiocarcinoma
in primary sclerosing cholangitis. Am J Gastroenterol. 99:523–526.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Morris-Stiff G, Bhati C, Olliff S, et al:
Cholangiocarcinoma complicating primary sclerosing cholangitis: a
24-year experience. Dig Surg. 25:126–132. 2008.PubMed/NCBI
|
|
5.
|
Sheu BS, Yang HB, Sheu SM, Huang AH and Wu
JJ: Higher gastric cyclooxygenase-2 expression and precancerous
change in Helicobacter pylori-infected relatives of gastric
cancer patients. Clin Cancer Res. 9:5245–5251. 2003.PubMed/NCBI
|
|
6.
|
Takasu S, Tsukamoto T, Cao XY, et al:
Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1
expression and beta-catenin activation in gastric carcinogenesis in
N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice. Cancer
Sci. 99:2356–2364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Giannitrapani L, Inqrao S, Soresi M, et
al: Cycloxygenase-2 expression in chronic liver disease and
hepatocellular carcinoma: an immunohistochemical study. Ann NY Acad
Sci. 1155:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Takii Y, Abiru S, Fujioka H, et al:
Expression of microsomal prostaglandin E synthase-1 in human
hepatocellular carcinoma. Liver Int. 17:989–996. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Talero E, Sánchez-Fidalgo S, Villegas I,
de la Lastra CA, Illanes M and Motilva V: Role of different
inflammatory and tumor biomarkers in the development of ulcerative
colitis-associated carcinogenesis. Inflamm Bowel Dis. 17:696–710.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wilson KT, Fu S, Ramanujam KS and Meltzer
SJ: Increased expression of inducible nitric oxide synthase and
cyclooxygenase-2 in Barrett’s esophagus and associated
adenocarcinoma. Cancer Res. 58:2929–2934. 1998.
|
|
11.
|
Jang TJ, Min SK, Bae JD, et al: Expression
of cycloxygenase-2, microsomal prostaglandin E synthase 1, and EP
receptors is increased in rat oesophageal squamous cell dysplasia
and Barrett’s metaplasia induced by duodenal contents reflux. Gut.
53:27–33. 2004.PubMed/NCBI
|
|
12.
|
Wang D and Dubois RN: Eicosanoids and
cancer. Nat Rev Cancer. 10:181–193. 2010. View Article : Google Scholar
|
|
13.
|
Koga H, Sakisaka S, Ohishi M, et al:
Expression of cyclooxygenase-2 in human hepatocellular carcinoma:
relevance to tumor dedifferentiation. Hepatology. 29:688–696. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Wendum D, Masliah J, Trugnan G and Fléjou
JF: Cyclooxygenase-2 and its role in colorectal cancer development.
Virchows Arch. 445:327–333. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Jang TJ: Expression of proteins related to
prostaglandin E2 biosynthesis is increased in human gastric and
during gastric carcinogenesis. Virchows Arch. 445:564–571. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Davies G, Martin LA, Sacks N and Dowsett
M: Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a
possible role for COX-2 inhibitors in breast cancer
chemoprevention. Ann Oncol. 13:669–678. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ermert L, Dierkes C and Ermert M:
Immunohistochemical expression of cyclooxygenase isoenzymes and
downstream enzymes in human lung tumors. Clin Cancer Res.
9:1604–1610. 2003.PubMed/NCBI
|
|
18.
|
Hayashi N, Yamamoto H, Hiraoka N, et al:
Differential expression of cyclooxygenase-2 (COX-2) in human bile
duct epithelial cells and bile duct neoplasm. Hepatology.
34:638–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Endo K, Yoon BI, Pairojkul C, Demetris AJ
and Sirica AE: ERBB-2 overexpression and cyclooxygenase-2
up-regulation in human cholangiocarcinoma and risk conditions.
Hepatology. 36:439–450. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Chariyalersak S, Sirikulchayanonta V,
Mayer D, et al: Aberrant cyclooxygenase isozyme expression in human
intrahepatic cholangiocarcinoma. Gut. 48:80–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Wu GS, Wang JH, Liu ZR and Zou SQ:
Expression of cyclooxygenase-1 and -2 in extra-hepatic
cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 1:429–433.
2002.PubMed/NCBI
|
|
22.
|
Kim HJ, Lee KT, Kim EK, et al: Expression
of cyclooxygenase-2 in cholangiocarcinoma: correlation with
clinicopathological features and prognosis. J Gastroenterol
Hepatol. 19:582–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Nzeako UC, Guicciardi ME, Yoon JH, Bronk
SF and Gores GJ: COX-2 inhibits Fas-mediated apoptosis in
cholangiocarcinoma cells. Hepatology. 35:552–559. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wu T, Han C, Lunz JG 3rd, Michalopoulos G,
Shelhamer JH and Demetris AJ: Involement of 85-kd cytosolic
phospholipase A2 and cyclooxygenase-2 in the proliferation of human
cholangiocarcinoma cells. Hepatology. 36:363–373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Han C and Wu T: Cyclooxygenase-2 derived
prostaglandin E2 promotes human cholangiocarcinoma cell growth and
invasion through EP1 receptor-mediated activation of the epidermal
growth factor receptor and Akt. J Biol Chem. 280:24053–24063. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Tsuneoka N, Tajima Y, Kitazato A, et al:
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor
(etodolac) on chemically induced biliary carcinogenesis in
hamsters. Carcinogenesis. 29:830–833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Jaiswal M, LaRusso NF, Shapiro RA, Billar
TR and Gores GJ: Nitric oxide-mediated inhibition of DNA repair
potentiates oxidative DNA damage in cholangiocytes.
Gastroenterology. 120:190–199. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Komori J, Marusawa H, Machimoto T, et al:
Activation-induced cytidine deaminase links bile duct inflammation
to human cholangiocarcinoma. Hepatology. 47:888–896. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Jakobsson PJ, Thorén S, Morgenstern R and
Samuelsson B: Identification of human E synthase: a microsomal,
glutathione-dependent, inducible enzyme, constituting a potential
novel drug target. Proc Natl Acad Sci USA. 96:7220–7225. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Yoshimitsu K, Altorki NK, Golojanin D, et
al: Inducible prostaglandin E synthase is overexpressed in
non-small cell lung cancer. Clin Cancer Res. 7:2669–2674.
2001.PubMed/NCBI
|
|
31.
|
Van Rees BP, Sivula A, Thorén S, et al:
Expression of microsomal prostaglandin E synthase-1 in intestinal
type gastric adenocarcinoma and in gastric cancer cell lines. Int J
Cancer. 107:551–556. 2003.PubMed/NCBI
|
|
32.
|
Yoshimatsu K, Golijanin D, Paty PB, et al:
Inducible prostaglandin E synthase is overexpressed in colorectal
adenomas and cancer. Clin Cancer Res. 7:3971–3976. 2001.PubMed/NCBI
|
|
33.
|
Mehrotra S, Morimiya A, Agarwal B, Konger
R and Badve S: Microsomal prostaglandin E2 synthase-1 in breast
cancer: a potential target for therapy. J Pathol. 208:356–363.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Kawata R, Hyo S, Araki M and Takenaka H:
Expression of cyclooxygenase-2 and microsomal prostaglandin E
synthase-1 in head and neck squamous cell carcinoma. Auris Nasus
Larynx. 37:482–487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lu D, Han C and Wu T: Microsomal
prostaglandin E synthase-1 inhibits PTEN and promotes experimental
cholangiocarcinogenesis and tumor progression. Gastroenterology.
140:2084–2094. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Tanabe T and Tohnai N: Cyclooxygenase
isozymes and their gene structures and expression. Rostaglandins
Other Lipid Mediat. 68–69:95–114. 2002.PubMed/NCBI
|
|
37.
|
Subbaramaiah K, Yoshimatsu K, Scheri E, et
al: Microsomal prostaglandin E synthase-1 is overexpressed in
inflammatory bowel disease. Evidence for involvement of
transcription factor Egr-1. J Biol Chem. 279:12647–12658. 2004.
View Article : Google Scholar : PubMed/NCBI
|
